Maine-based Covetrus makes Europe-based organizational changes
Covetrus Inc. (Nasdaq: CVET), the Portland-based animal health technology and services company, is making organizational changes overseas, including moves to bolster the company's business in the U.K. and Germany.
Earlier this year, Covetrus announced the hiring of András Bolcskei as the first president of the company's International business unit. Bolcskei was charged with bringing all commercial teams outside of North America together, and Covetrus said Tuesday the new changes will move that plan ahead.
Among the measures, Covetrus will move its headquarters in Germany from Hamburg to Düsseldorf, effective April 1. The proximity to two other Covetrus regions, Belgium and the Netherlands, will improve efficiency within their commercial teams, the company said in a news release.
Meanwhile, effective Jan. 1, the U.K. commercial and Global Technology Solutions units and the European sales teams will come under a single commercial team led by Loic Jegou, Covetrus vice president of northern Europe.
Jegou joined Covetrus last month with 18 years of experience in the animal health pharmaceutical business at Pfizer and MSD Animal Health.
“I have absolute confidence in our ability to drive our strategy, win back our position within the German and U.K. markets, drive greater outcomes for our customers and the animals they care for and drive success for all our teams and stakeholders,” said Ben Wolin, Covetrus’ president and CEO.
The company said it's adopting the same strategy in Australia and New Zealand.
Covetrus provides a range of technology and services for over 100,000 veterinary practices around the world, and employs more than 5,500 people including about 1,000 in Maine.
The company reported 2020 revenues of $4.3 billion, ranking Covetrus first among Maine-based public companies in the Mainebiz Book of Lists.
Most Recent
Most Recent
0 Comments